We use cookies to see how investors use El Fondo and make its tools, data and markets better for you. You can accept or reject; essential cookies always stay on. Privacy Policy
No fiscal-year history available for this company yet.
No P/E, the company is not profitable on a trailing basis.
Infinium Pharmachem Ltd. is a specialized chemical company engaged in the development, manufacture, and export of a wide range of iodine derivatives and Active Pharmaceutical Ingredients (APIs). The company's core focus is on iodine chemistry, providing over 200 iodine derivatives and more than 15 APIs. It also offers Contract Research and Manufacturing Services (CRAMS), which include research and development, process optimization, scale-up, and commercial-scale manufacturing and packaging for iodine-based compounds. Infinium Pharmachem serves diverse global industries such as pharmaceuticals, specialty and performance chemicals, nutraceuticals, animal feed, agriculture, biotech, cosmetics, electronics, and medical imaging. The company operates an ISO, FDA-approved, and GMP-compliant manufacturing facility in Gujarat, India, and supplies its products to markets across India, Europe, Asia, North America, Central America, the Middle East, and South America.
Loading the full price history…
Run your own numbersPast performance is not a forecast.
Save INFINIUM.NS and get told when something moves.
Get updates
A clear, direct weekly summary.
Learn the fundamentals behind this asset.
A stock is a fraction of ownership in a real company. Buy one share and you own a piece (usually a tiny piece) of every desk, factory, contract and brand the company runs. The price moves because the market keeps revising what that whole pie is worth.
The price-to-earnings ratio is how much investors are paying for one dollar of a company's profit. A multiple, never an absolute. Always compared to something: a sector, a region, the company's own past.
Dividend yield is the annual income a stock or ETF pays out, expressed as a percentage of what you paid for it. It is the visible part of total return: the cash that lands in your account every quarter, and the lever most retail investors actually feel.
Market cap is shares times price. A simple formula that produces wildly unequal numbers: a single US tech name can be worth more than every company on a LATAM exchange combined.
